Previous Close | 8.90 |
Open | 8.90 |
Bid | 6.50 |
Ask | 11.00 |
Strike | 25.00 |
Expire Date | 2026-01-16 |
Day's Range | 8.90 - 8.90 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
Celebrations may be in order for Prothena Corporation plc ( NASDAQ:PRTA ) shareholders, with the analysts delivering a...
The analysts might have been a bit too bullish on Prothena Corporation plc ( NASDAQ:PRTA ), given that the company fell...